Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Change in Account Payables (2016 - 2025)

Harte Hanks (HHS) has disclosed Change in Account Payables for 16 consecutive years, with -$497000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Account Payables fell 150.71% to -$497000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.9 million, a 210.83% decrease, with the full-year FY2024 number at -$795000.0, down 194.19% from a year prior.
  • Change in Account Payables was -$497000.0 for Q3 2025 at Harte Hanks, up from -$3.4 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $4.6 million in Q4 2023 to a low of -$7.0 million in Q1 2024.
  • A 5-year average of $91263.2 and a median of -$150000.0 in 2021 define the central range for Change in Account Payables.
  • Biggest YoY gain for Change in Account Payables was 2499.39% in 2022; the steepest drop was 396.82% in 2022.
  • Harte Hanks' Change in Account Payables stood at -$898000.0 in 2021, then skyrocketed by 258.35% to $1.4 million in 2022, then soared by 225.53% to $4.6 million in 2023, then tumbled by 74.21% to $1.2 million in 2024, then tumbled by 141.62% to -$497000.0 in 2025.
  • Per Business Quant, the three most recent readings for HHS's Change in Account Payables are -$497000.0 (Q3 2025), -$3.4 million (Q2 2025), and -$175000.0 (Q1 2025).